|
Post-market: Bulls bellow
|
Friday, June 26, 2009 |
| | Index Performance | Index | Sensex | Nifty | Open | 14,373.57 | 4,243.95 | High | 14,781.94 | 4,383.75 | Low | 14,373.57 | 4,243.95 | Today's Cls | 14,764.64 | 4,375.50 | Prev Cls | 14,345.62 | 4,241.85 | Change | 419.02 | 133.65 | % Change | 2.92 | 3.15 | | | Market Indicators | Top Movers (Group A) | Company | Price (Rs) | % chg | Gainers | HDIL | 252.10 | 11.30 | IVRCL Infra | 377.75 | 9.11 | Videocon Industries | 181.65 | 8.64 | ICICI Bank | 754.35 | 7.96 | Sintex | 222.00 | 7.66 | Losers | Sun Pharma | 1,140.45 | -12.17 | Lupin | 843.40 | -5.52 | Ranbaxy Lab | 255.20 | -4.37 | Tata Steel | 387.90 | -2.53 | TTML | 38.50 | -1.16 | | Market Statistics | - | BSE | NSE | Advances | 1,689 | 877 | Declines | 937 | 342 | Unchanged | 107 | 33 | Volume(Nos) | 38.36cr | 89.51cr | | | | | Market Commentary | | Bulls bellow | The stock market rallied sharply and closed above 14700-mark on sharp appreciation in banking and capital goods stocks. | After a subdued trend in the last week, the Sensex staged a recovery today and the Nifty scaled higher. The bulls were back in action after closing negative on Thursday, | | | as the market registered sharp gains on the back of all-round buying support. Taking cue from buoyant international indices, the Sensex resumed 28 points above its previous close at 14373 on the back of strong buying in heavyweight, banking, capital goods and fast moving consumer durable stocks. However health care stocks witnessed loss. This buoyancy triggered a major rally that propelled the index to an intra-day high of 14782. Though the Sensex held firm above 14600 for a major part of the session, it finally closed at 14765, up 419 points. Nifty advanced 134 points to close at its high at 4376. The market breadth was positive on the BSE, with the gainers outpacing the losers in the ratio of 1.76:1. Of the 2,733 stocks traded on the BSE 1,689 stocks advanced, while 937 stocks declined. Hundred and seven stocks ended unchanged. Out of 13 sectoral indices on the BSE, all bar the BSE HC posted gains for the day. The BSE Bankex and BSE CG ended firm with gains of above 4% each, while BSE IT rose 3.64% and BSE CD added 3.17%. Action in several index heavyweights lifted the market. ICICI Bank led the pack and shot 7.96% to Rs754.35. Sterlite Industries soared 6.11% to Rs612.05, Larsen &Toubro surged 5.47% to Rs1611.20, Tata Consultancy Services flared 4.35% to Rs396.90, Infosys Technologies jumped 3.93% to Rs1,826.75, Reliance Communications added 3.93% at Rs312.25, Reliance Industries advanced 3.53% to Rs2,028.65, Bharat Heavy Electricals moved up 3.20% to Rs2,201.50 and Maruti Suzuki India was up 3.12% to Rs1,058.95. Health care stocks, however, came under sharp selling pressure. Sun Pharmaceutical Industries at Rs1,140.45, Lupin at Rs843.40 and Ranbaxy Laboratories at Rs255.20 dropped over 4% each. Tata Steel at Rs387.90 and Mahindra & Mahindra at Rs697.50 were down around 1-2% each. Over 2.49 crore shares of IFCI changed hands on the BSE followed by Ispat Industries (1.82 crore shares), Suzlon Energy (1.68 crore shares), Unitech (1.58 crore shares), and Reliance Natural Resources (1.45 crore shares). | | | | | | | | European Indices at 16:00 IST on 26-06-2009 | | | Index | Level | Change (pts) | Change (%) | FTSE 100 Index | 4276.76 | 24.19 | 0.57 | CAC 40 Index | 3171.04 | 7.94 | 0.25 | DAX INDEX | 4830.68 | 30.12 | 0.63 | | | | | | | | Asian Indices at close on 26-06-2009 | | | Index | Level | Change (pts) | Change (%) | Nikkei 225 | 9877.39 | 81.31 | 0.83 | Hang Seng Index | 18600.26 | 325.23 | 1.78 | Kospi Index | 1394.53 | 1.80 | 0.13 | Straits Times Index | 2317.96 | 15.50 | 0.67 | Jakarta Composite Index | 2040.19 | -3.97 | -0.19 | | | | | | | | To know more about our products and services, click here. | | | | | | ?This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report. The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (?SHAREKHAN and affiliates?) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.? | To unsubscribe write to myaccount@sharekhan.com
| | | Manage your newsletter subscriptions |  |
posted by Anonymous @ 10:22 AM  |
|
|
|
|